Improving the outcome of invasive aspergillosis: New diagnostic tools and new therapeutic strategies

Annals of Hematology

Volumn 81, Issue SUPPL. 2, 2002, Pages

  Herbrecht, R ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CASPOFUNGIN; GALACTOMANNAN; ITRACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TOLERABILITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEBRILE NEUTROPENIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SURVIVAL; TREATMENT OUTCOME; VISUAL DISORDER;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; HUMANS; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 0036990132     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34: 7-14
2. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139-147
3. Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563-571
4. Espinel-Ingroff A (2001) In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dermatiaceous fungi. J Clin Microbiol 39:954-958
5. Herbrecht R, Denning DW, Patterson TF, Kern W, Marr K, Caillot D, Thiel E, Ribaud P, Lortholary O, Greene R, Durand C, Oestmann JW, Stark P, Sylvester R, Troke P, Schlamm H, Wingard JR, Rubin RH, de Pauw B, Bennett JE. (2001) Open, randomised comparison of voriconazole and amphotericin B followed by other licensed antifungal therapy for primary therapy of invasive aspergillosis. Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, abstract J-680 p. 378, Chicago, USA
6. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz P, Dufour P, Bergerat JP, Candolfi E (2002) Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20:1898-1906
7. Kirkpatrick WR, McAtee RK, Fothergill AW, Rinaldi MG, Patterson TF (2000) Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis. Antimicrob Agents Chemother 44:2865-2868
8. Maertens J, Raad I, Sable CA, Ngai A, Berman R, Patterson TF, Denning D, Walsh T. (2000) Multicenter, non comparative study to evaluate safety and efficacy of caspofungin in adults with invasive aspergillosis refractory or intolerant to amphotericin B, AMB lipid formulations, or azoles. American Society for Microbiology, Washington DC. Program and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy: Abstract J-1103, p.371. Toronto, Canada
9. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M (2001) Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 97:1604-1610
10. Tiphine M, Letscher-Bru V, Herbrecht R (1999) Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability. Transpl Infect Dis 1:273-283
11. Verweij PE, Stynen D, Rijs AJ, de Pauw BE, Hoogkamp-Korstanje JA, Meis JF (1995) Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 33:1912-1914
12. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. (1995) Pulmonary aspergillosis: early diagnosis improves survival. Respiration 62:341-347
13. Wald A, Leisenring W, van Burik JA, Bowden RA (1997) Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175:1459-1466